Cel Sci Corporation (CVM)

[Biobonic]

Another shot at the short thesis that the trial has failed.

The link is to:

Feb 10, 2020 CLINICAL CENTER OF VOJVODINA Ethics Committee meeting agenda

CLINICAL CENTER OF VOJVODINA (Bosnia)
ETHICS COMMITTEE
President of the Ethics Committee,
6 Number: 00-79
Date: 10.02.2020.
Novi Sad

It is an invite:

You are invited to attend the 228th session of the Ethics Committee of the Clinical Center of Vojvodina, which will
to be held on 13.02.2020. (Thursday) in the premises of the Management of the Clinical Center of Vojvodina,
starting at 12:30 p.m.
The following is proposed for the session

Amongst the items on the agenda is: (Line item 9)

Submission of a quarterly report on the course of the clinical trial entitled "Multicenter, a randomized phase III study, an open-label type of leukocyte injection efficacy interleukin [Multikine®] with standard therapy [surgery + radiotherapy or surgery + concomitant chemoradiotherapy) compared to standard patient therapy alone with advanced primary squamous cell carcinoma of the oral cavity or soft palate ” Protocol CS001P3, principal investigator prof. Dr. Aleksandar Kiralj;

The Clinical Center of Vojvodina was holding a meeting in Feb 2020 about the Multikine trial in their country.
They are witness to the trial data and were, at that time still presenting minutes of the trial to a quarterly Ethics committee meeting.